What Is Spravato? A Complete Guide to Esketamine Treatment

Short answer: Spravato is the brand name for esketamine, a nasal spray derived from part of the ketamine molecule, and it is the only ketamine-family treatment with full FDA approval for depression, specifically treatment-resistant depression and depression with acute suicidal thoughts. It is taken in a certified clinic under a federal monitoring program, usually twice weekly at first, and because it is FDA approved, insurance frequently covers it. Here is the complete picture.

What esketamine actually is

Ketamine is a molecule made of two mirror-image halves, and esketamine is one of those halves, isolated and formulated as a nasal spray. It works the same fundamental way as ketamine, blocking NMDA receptors and triggering the rapid growth of new neural connections we described in how ketamine works in the brain, and it produces the same family of effects: fast-acting relief, a temporary dissociative experience, and benefits that build across repeated sessions. The FDA approved it in 2019 for treatment-resistant depression and in 2020 for depressive symptoms with acute suicidal thinking, the approval story we told in is ketamine FDA approved.

What treatment looks like

Spravato is never a take-home prescription. Under its federal REMS safety program, every dose is self-administered as a nasal spray in a certified clinic, followed by about two hours of monitoring before you leave with your arranged ride. The standard schedule starts with twice-weekly sessions for four weeks, moves to weekly, and then stretches toward every week or two for maintenance, always alongside an oral antidepressant, which the approval requires. The session experience resembles a gentler cousin of an infusion: dissociation, rest, music if you like, and the same no-driving rule for the day.

Spravato versus IV ketamine

The honest comparison we drew in ketamine versus Spravato comes down to trade-offs. IV ketamine offers precise, adjustable, fully absorbed dosing and fewer total visits; Spravato offers FDA approval and with it the insurance pathway, with major insurers covering it after prior authorization, often at a fraction of self-pay cost. Clinically, some patients respond better to one than the other, and there is no way to know in advance. Both demand the same seriousness: screening, monitoring, and a clinic that knows the medication.

Who Spravato is for

The approval defines the lane: adults with treatment-resistant depression, generally meaning two adequate antidepressant trials without sufficient relief, or major depression with acute suicidal thoughts or behavior, taken together with an oral antidepressant. The usual medical exclusions apply, including uncontrolled blood pressure and certain vascular conditions. For people whose insurance approves it, Spravato is often the most financially accessible way into ketamine-family treatment.

Where we stand

Ketamine Uplift now offers Spravato alongside our IV ketamine program, fully credentialed, under the same physician-led standards Dr. O'Neill applies to everything we do. That lets us match the treatment to the person: Spravato when approval and insurance align, IV ketamine when precision, speed, or self-pay economics favor it, and an honest recommendation either way. Spravato consultations are available now.

This article is for educational purposes only and is not medical advice. Whether Spravato is appropriate for you is a decision for qualified providers.

The bottom line

Spravato is FDA-approved esketamine, a nasal spray for treatment-resistant depression taken in certified clinics under monitoring, usually insurance-covered after prior authorization, and always paired with an oral antidepressant. It is the regulated, on-label door into ketamine-family treatment, and it is now available at Ketamine Uplift. Questions about whether it fits your situation? Call (310) 280-4440.

Frequently asked questions

What is Spravato used for? Treatment-resistant depression in adults, and depressive symptoms in adults with major depression and acute suicidal thoughts or behavior, always in combination with an oral antidepressant.

How is Spravato different from ketamine? Esketamine is one half of the ketamine molecule, given as a nasal spray with FDA approval and an insurance pathway. IV ketamine is the full molecule, delivered with more dosing precision but off-label and usually self-pay.

How often do you take Spravato? Typically twice weekly for the first four weeks, then weekly, then every one to two weeks for maintenance, each session followed by about two hours of in-clinic monitoring.

Is Spravato covered by insurance? Often yes, after prior authorization documenting treatment-resistant depression. Most insured patients pay far less than the self-pay price, sometimes as little as ten dollars per session with copay assistance.